2-[6-(quinolin-2-ylmethoxy)naphthalen-2-yl]-N-[[4-(2H-tetrazol-5-yl)phenyl]methyl]acetamide
C30H24N6O2 — CID 10481103
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[6-(quinolin-2-ylmethoxy)naphthalen-2-yl]-N-[[4-(2H-tetrazol-5-yl)phenyl]methyl]acetamide
2-[6-(quinolin-2-ylmethoxy)naphthalen-2-yl]-N-[[4-(2H-tetrazol-5-yl)phenyl]methyl]acetamide (PubChem CID 10481103) has the molecular formula C30H24N6O2 and a molecular weight of 500.56 g/mol. Its IUPAC name is 2-[6-(quinolin-2-ylmethoxy)naphthalen-2-yl]-N-[[4-(2H-tetrazol-5-yl)phenyl]methyl]acetamide.
Molecular Properties
| Compound Name | 2-[6-(quinolin-2-ylmethoxy)naphthalen-2-yl]-N-[[4-(2H-tetrazol-5-yl)phenyl]methyl]acetamide |
|---|---|
| PubChem CID | 10481103 |
| Molecular Formula | C30H24N6O2 |
| Molecular Weight | 500.56 g/mol |
| Exact Mass | 500.20 |
| IUPAC Name | 2-[6-(quinolin-2-ylmethoxy)naphthalen-2-yl]-N-[[4-(2H-tetrazol-5-yl)phenyl]methyl]acetamide |
| SMILES | O=C(Cc1ccc2cc(OCc3ccc4ccccc4n3)ccc2c1)NCc1ccc(-c2nn[nH]n2)cc1 |
| InChI | InChI=1S/C30H24N6O2/c37-29(31-18-20-5-8-23(9-6-20)30-33-35-36-34-30)16-21-7-10-25-17-27(14-12-24(25)15-21)38-19-26-13-11-22-3-1-2-4-28(22)32-26/h1-15,17H,16,18-19H2,(H,31,37)(H,33,34,35,36) |
| InChIKey | VRNGVHXOTQCSCX-UHFFFAOYSA-N |
| XLogP | 5.01 |
| TPSA | 105.68 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 500.56 |
| LogP ≤ 5 | 5.01 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 10481103 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.